CONTINUE TO SITE

OR WAIT null SECS

Antifungal Resistance in Vulvovaginal Candidiasis (VVC) Infections, Alternative Treatment Options Better For Women Series Chlamydia Screening Post COVID-19 Consortium for Sexual Health and Wellness Enhanced Recovery for Cesarean Delivery: Perspectives From the Front Lines, Part 2 Management of Uterine Fibroids Mycoplasma Genitalium Infections NAMS Rationale for a New Method of Contraception

Antifungal Resistance in Vulvovaginal Candidiasis (VVC) Infections, Alternative Treatment OptionsBetter For Women SeriesChlamydia Screening Post COVID-19Consortium for Sexual Health and WellnessEnhanced Recovery for Cesarean Delivery: Perspectives From the Front Lines, Part 2Management of Uterine FibroidsMycoplasma Genitalium InfectionsNAMSRationale for a New Method of Contraception

Clinical

View More Contraception Curbside Consults Gynecology Legally Speaking Life Transitions Obstetrics Residents Corner Vulvovaginal Disease Well Woman

ContraceptionCurbside ConsultsGynecologyLegally SpeakingLife TransitionsObstetricsResidents CornerVulvovaginal DiseaseWell Woman

About

News

All News Contraception COVID-19 Endometriosis Infertility Menopause Sexual Health Uterine Fibroids

All NewsContraceptionCOVID-19EndometriosisInfertilityMenopauseSexual HealthUterine Fibroids

Media

K-Cast Medical World News Podcasts Quizzes Videos Viewpoints

K-CastMedical World NewsPodcastsQuizzesVideosViewpoints

Conferences

Conference Coverage Conference Listing

Conference CoverageConference Listing

Publications

Contemporary OB/GYN® Journal Digital Supplements Peer Reviewed Articles Supplements and Featured Publications

Contemporary OB/GYN® JournalDigital SupplementsPeer Reviewed ArticlesSupplements and Featured Publications

CME/CE

Resources

Physician Fact Sheets Job Board

Physician Fact SheetsJob Board

eNewsletter Print Subscription

eNewsletterPrint Subscription

Editorial Board

Meet the Board

Partnerships

Advertise
Contact Us
Job Board
Editorial
Terms of Use
Privacy Policy
Do Not Sell My Personal Information

Spotlight

Antifungal Resistance in Vulvovaginal Candidiasis (VVC) Infections, Alternative Treatment Options
Better For Women Series
Chlamydia Screening Post COVID-19
Consortium for Sexual Health and Wellness
Enhanced Recovery for Cesarean Delivery: Perspectives From the Front Lines, Part 2
Management of Uterine Fibroids
Mycoplasma Genitalium Infections
NAMS
Rationale for a New Method of Contraception

ClinicalSee All >

Contraception
Curbside Consults
Gynecology
Legally Speaking
Life Transitions
Obstetrics
Residents Corner
Vulvovaginal Disease
Well Woman

Advertise
Contact Us
Job Board
Editorial
Terms of Use
Privacy Policy
Do Not Sell My Personal Information

Scarring Post-Ablation

November 8, 2012

What physiological changes occur in the uterus after ablation? Are there differences in uterine scarring depending on GEA method? Is assessment of the uterine cavity limited after GEA, in particular the NovaSure GEA? What is the incidence of endometrial cancer after GEA and is it masked by changes to the uterine cavity post-ablation?